CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells.
Zhou S, Lin W, Jin X, Niu R, Yuan Z, Chai T, Zhang Q, Guo M, Kim SS, Liu M, Deng Y, Park JB, Choi SI, Shi B, Yin J.
Zhou S, et al. Among authors: niu r.
Cell Rep Med. 2024 Dec 17;5(12):101844. doi: 10.1016/j.xcrm.2024.101844. Epub 2024 Dec 4.
Cell Rep Med. 2024.
PMID: 39637858
Free article.